Page last updated: 2024-08-24

gemcitabine and Neuroendocrine Tumors

gemcitabine has been researched along with Neuroendocrine Tumors in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endoh, T; Ikeda, K; Iwata, N; Minami, T; Sasano, H; Sugawara, N; Yoshida, Y1
Garcon, MC; Kaley, K; Rodriguez, T; Saif, MW1
Dussol, AS; Forestier, J; Hervieu, V; Joly, MO; Lombard-Bohas, C; Scoazec, JY; Vercherat, C; Walter, T1
Bajor, J; Balázs, A; Czakó, L; Czimmer, J; Farkas, G; Gódi, S; Halász, A; Hegyi, P; Izbéki, F; Kahán, Z; Kelemen, D; Kui, B; Lakatos, G; Leindler, L; Papp, R; Pár, G; Szabó, I; Szentesi, A; Szentkereszty, Z; Szepes, Z; Szmola, R; Szücs, Á; Takács, T; Vincze, Á1
Abou-Alfa, GK; Blumgart, LH; Capanu, M; D'Angelica, M; Dematteo, RP; Duffy, A; Fong, Y; Huitzil, D; Jarnagin, W; O'Reilly, EM1
Gruber, T; Hammerstingl, R; Naguib, NN; Nour-Eldin, NE; Vogl, TJ1
Clark, JW; Enzinger, PC; Fuchs, CS; Kim, H; Kulke, MH; Lynch, TJ; Michelini, A; Morgan, JA; Vincitore, M1
Arias de la Vega, F; Gómez Dorronsoro, ML; Jiménez, FJ1
Hayashi, H; Igarashi, H; Ito, T; Kawabe, K; Kodama, M; Sakai, H; Takayanagi, R; Yoshinaga, M1

Trials

1 trial(s) available for gemcitabine and Neuroendocrine Tumors

ArticleYear
A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.
    Cancer, 2004, Sep-01, Volume: 101, Issue:5

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neuroendocrine Tumors; Prognosis; Survival Rate; Treatment Outcome

2004

Other Studies

8 other study(ies) available for gemcitabine and Neuroendocrine Tumors

ArticleYear
[A case of pancreatic neuroendocrine tumor with excessively-advanced liver metastasis treated with S-1/GEM combination chemotherapy plus the long-acting somatostatin analogue octreotide].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2013, Volume: 110, Issue:4

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Liver Neoplasms; Neuroendocrine Tumors; Octreotide; Oxonic Acid; Pancreatic Neoplasms; Tegafur

2013
Gemcitabine as salvage treatment in patients with poorly differentiated pancreatic neuroendocrine tumors: a case series.
    JOP : Journal of the pancreas, 2014, Jan-10, Volume: 15, Issue:1

    Topics: Aged; Antimetabolites, Antineoplastic; Cell Differentiation; Deoxycytidine; Drug Evaluation; Fatal Outcome; Female; Gemcitabine; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Salvage Therapy; Treatment Outcome

2014
Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice.
    Cancer, 2015, Oct-01, Volume: 121, Issue:19

    Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Neuroendocrine Tumors; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Treatment Outcome

2015
Pancreatic Cancer: Multicenter Prospective Data Collection and Analysis by the Hungarian Pancreatic Study Group.
    Journal of gastrointestinal and liver diseases : JGLD, 2016, Volume: 25, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Cholangiopancreatography, Endoscopic Retrograde; Deoxycytidine; Diabetes Mellitus; Female; Gemcitabine; Humans; Hungary; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neuroendocrine Tumors; Palliative Care; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis, Chronic; Prognosis; Proportional Hazards Models; Prospective Studies; Registries; Risk Factors; Smoking; Stents; Young Adult

2016
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).
    Journal of surgical oncology, 2008, Dec-01, Volume: 98, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Cholecystectomy; Cholecystectomy, Laparoscopic; Deoxycytidine; Female; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Hepatectomy; Humans; Incidental Findings; Male; Middle Aged; Neoplasm, Residual; Neuroendocrine Tumors; Radiotherapy, Adjuvant; Retrospective Studies; Sarcoma; Survival Analysis

2008
Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.
    AJR. American journal of roentgenology, 2009, Volume: 193, Issue:4

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Deoxycytidine; Female; Gemcitabine; Hemostatics; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neuroendocrine Tumors; Retrospective Studies; Treatment Outcome

2009
Subcutaneous metastasis as the first manifestation of a solid-pseudopapillary tumor of the pancreas.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:2

    Topics: Adenocarcinoma, Clear Cell; Aged; Antimetabolites, Antineoplastic; Arm; Biomarkers; Biomarkers, Tumor; Deoxycytidine; Diagnostic Errors; Female; Gemcitabine; Humans; Keratins; Neoplasm Proteins; Neprilysin; Neuroendocrine Tumors; Pancreatic Neoplasms; Phosphopyruvate Hydratase; Soft Tissue Neoplasms; Subcutaneous Tissue; Vimentin

2006
Successful management of multiple liver metastases from pancreatic neuroendocrine tumor by hepatic arterial administration of cisplatin powder.
    Pancreas, 2007, Volume: 35, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Deoxycytidine; Drug Carriers; Female; Gemcitabine; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pancreaticoduodenectomy; Powders; Remission Induction

2007